Cover Image
Market Research Report

Global Markets for Blood Plasma Products

Published by BCC Research Product code 528120
Published Content info 149 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Markets for Blood Plasma Products
Published: December 19, 2018 Content info: 149 Pages
Description

Report Highlights:

The global blood plasma products market should reach $35.5 billion by 2023 from $25.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.6% for the period 2018-2023.

North America region of the global blood plasma products market is expected to grow from $10.9 billion in 2018 to $14.7 billion in 2023 at a CAGR of 6.2% for the period 2018-2023.

Asia-Pacific region of the global blood plasma products market is expected to grow from $5.8 billion in 2018 to $9.2 million in 2023 at a CAGR of 9.5% for the period 2018-2023.

Report Scope:

This research report presents an in-depth analysis of the global blood plasma market by product type, application, end user, and geographic market. In addition, report provides qualitative information related to the mode of delivery for blood plasma.

The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. The report also featu res an in-depth analysis of key companies operating in the global blood plasma market and patents that highlight past, current and projected global technology trends. The blood plasma market is primarily segmented into five major blood plasma components: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunoglobulins are further segmented into intravenous immunoglobulins, subcutaneous immunoglobulins and normal immunoglobulins such as immunoglobulin A (IgA), immunoglobin D (IgD), immunoglobin E (IgE), immunoglobin G (IgG), and immunoglobin M (ISM). The global blood plasma market is further segmented by application, which helps in understanding the potency of blood plasma products in several therapeutic treatments. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma market is segmented as hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.

In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions like the U.S., Canada, Mexico, Europe (U.K., Italy, France, Germany and Spain), China, India and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2017 as the base year and forecasting forward to 2023. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers' total revenues. The projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market's supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches, and pipeline products are provided.

Report Includes:

  • 52 data tables and 24 additional tables
  • Industry analysis of the global market for blood plasma products
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
  • Qualitative information related to mode of delivery for blood plasma
  • Key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education
  • Profiles of the major players in the industry, including ADMA Biologics Inc., Baxter International Inc., Creat Group, Octapharma AG, Shire Plc and TCS Biosciences Ltd.
Table of Contents
Product Code: HLC201B

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Introduction to Blood Plasma Products
  • Components of Blood Plasma
  • Functions of Blood Plasma
  • Blood Donation
    • Collection and Extraction of Blood Plasma
    • Fractionation Methods for Extracting Individual Components from Plasma
  • Government Funding of Blood Donation Facilities
  • Government Regulations: FDA, International Regulatory Agencies and Medical Associations
  • Clinical Guidelines
  • Technology Trends
  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities

Chapter 4: Market Breakdown by Product Type

  • Overall Market Size and Forecast
  • Immunoglobulins
    • Market Size and Forecast by Region
    • Market Size and Forecast by Subsegment
  • Albumin
    • Market Size and Forecast by Region
  • Coagulation Factor Concentrates
    • Market Size and Forecast by Region
  • Hyperimmune Globulin
    • Market Size and Forecast by Region
  • Other Plasma Fractionation Products
    • Market Size and Forecast by Region

Chapter 5: Market Breakdown by Application

  • Overall Market Size and Forecast
  • Neurology
    • Market Size and Forecast by Region
  • Immunology
    • Market Size and Forecast by Region
  • Oncology
    • Market Size and Forecast by Region
  • Transplants
    • Market Size and Forecast by Region
  • Hematology
    • Market Size and Forecast by Region
  • Rheumatology
    • Market Size and Forecast by Region
  • Pulmonology
    • Market Size and Forecast by Region
  • Others
    • Market Size and Forecast by Region

Chapter 6: Market Breakdown by End User

  • Overall Market Size and Forecast
  • Hospitals and Clinics
    • Market Size and Forecast by Region
  • Research Laboratories
    • Market Size and Forecast by Region
  • Academic Institutions
    • Market Size and Forecast by Region
  • Blood Transfusion Centers
    • Market Size and Forecast by Region

Chapter 7: Mode of Delivery for Blood Plasma

  • Infusion Solutions
  • Gels
  • Sprays
  • Biomedical Sealants

Chapter 8: Market Breakdown by Region

  • Overall Market Size and Forecast by Region
  • North America
    • U.S. Market Size and Forecast
    • Canadian Market Size and Forecast
    • Mexican Market Size and Forecast
    • Market Size and Forecast by Product Type
    • Market Size and Forecast by Application
    • Market Size and Forecast by End User
  • Europe
    • German Market Size and Forecast
    • French Market Size and Forecast
    • Italian Market Size and Forecast
    • Spanish Market Size and Forecast
    • U.K. Market Size and Forecast
    • Rest of Europe Market Size and Forecast
    • Market Size and Forecast by Product Type
    • Market Size and Forecast by Application
    • Market Size and Forecast by End User
  • Asia-Pacific
    • Japanese Market Size and Forecast
    • Chinese Market Size and Forecast
    • Indian Market Size and Forecast
    • Australian Market Size and Forecast
    • South Korean Market Size and Forecast
    • Rest of Asia-Pacific Market Size and Forecast
    • Market Size and Forecast by Product Type
    • Market Size and Forecast by Application
    • Market Size and Forecast by End User
  • RoW
    • Latin American Market Size and Forecast
    • Middle Eastern Market Size and Forecast
    • African Market Size and Forecast
    • Other Countries Market Size and Forecast
    • Market Size and Forecast by Product Type
    • Market Size and Forecast by Application
    • Market Size and Forecast by End User

Chapter 9: Patent Review

Chapter 10: Competitive Landscape

  • Overview
  • Major Players and Market Shares
  • Porter's Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of New Suppliers
    • Threat of Substitutes
    • Competitive Rivalry/Degree of Competition
  • Major Developments
    • Mergers and Acquisitions
    • New Product Launches and Product Approvals
    • Agreements, Collaborations Business Expansions, and Partnerships

Chapter 11: Company Profiles

  • ADMA BIOLOGICS INC.
    • Business Overview
    • Products and Services
    • Company Financials
    • Developments and Strategies
  • ARTHREX INC.
    • Business Overview
    • Products and Services
  • BAXTER INTERNATIONAL
    • Business Overview
    • Products and Services
    • Company Financials
  • CERUS CORP.
    • Business Overview
    • Products and Services
    • Company Financials
  • CHINA BIOLOGIC PRODUCTS INC.
    • Business Overview
    • Products and Services
    • Company Financials
    • Developments and Strategies
  • CSL LTD.
    • Business Overview
    • Products and Services
    • Company Financials
    • Developments and Strategies
  • CREAT GROUP
    • Business Overview
    • Products and Services
    • Developments and Strategies
  • GENERAL ELECTRIC CO.
  • GRIFOLS INTERNATIONAL SA
    • Business Overview
    • Products and Services
    • Company Financials
    • Developments and Strategies
  • INNOVATIVE RESEARCH
    • Business Overview
  • INTAS PHARMACEUTICALS LTD.
    • Business Overview
  • KEDRION SPA
    • Business Overview
    • Products and Services
    • Company Financials
    • Developments and Strategies
  • LFB SA
    • Business Overview
  • OCTAPHARMA AG
    • Business Overview
    • Products and Services
    • Company Financials
    • Developments and Strategies
  • PRIME BIOLOGICS PTE. LTD.
    • Business Overview
  • SANQUIN
    • Business Overview
  • SHANGHAI RAAS
    • Business Overview
  • SHIRE PLC
    • Business Overview
    • Products and Services
    • Company Financials
    • Developments and Strategies
  • TCS BIOSCIENCES LTD.

List of Tables

  • Summary Table: Global Market for Blood Plasma Products, by Region, Through 2023
    • Table 1: Blood Plasma Components
    • Table 2: Percentage of Major Proteins Present in Different Fractions After Cohn's Fractionation Method
    • Table 3: Key Trends in the Global Blood Plasma Market
    • Table 4: Global Market for Blood Plasma, by Product Type, Through 2023
    • Table 5: Global Market for Immunoglobulins, by Region, Through 2023
    • Table 6: Global Market for Immunoglobulins, by Product Subsegment, Through 2023
    • Table 7: Global Market for Intravenous Immunoglobulin, by Region, Through 2023
    • Table 8: Global Market for Subcutaneous Immunoglobulins, by Region, Through 2023
    • Table 9: Global Market for Other Immunoglobulins, by Region, Through 2023
    • Table 10: Global Market for Albumins, by Region, Through 2023
    • Table 11: Global Market for Coagulation Factor Concentrates, by Region, Through 2023
    • Table 12: Global Market for Hyperimmune Globulins, by Region, Through 2023
    • Table 13: Protease Inhibitors Used in the Treatment of HIV
    • Table 14: Global Market for Other Plasma Fractionation Products, by Region, Through 2023
    • Table 15: Global Market for Blood Plasma Products, by Application, Through 2023
    • Table 16: Global Market for the Application of Blood Plasma Products in Neurology, by Region, Through 2023
    • Table 17: Global Market for the Application of Blood Plasma Products in Immunology, by Region, Through 2023
    • Table 18: Global Market for the Application of Blood Plasma Products in Oncology, by Region, Through 2023
    • Table 19: Global Market for the Application of Blood Plasma Products in Transplants, by Region, Through 2023
    • Table 20: Global Market for the Application of Blood Plasma Products in Hematology, by Region, Through 2023
    • Table 21: Global Market for the Application of Blood Plasma Products in Rheumatology, by Region, Through 2023
    • Table 22: Global Market for the Application of Blood Plasma Products in Pulmonology, by Region, Through 2023
    • Table 23: Global Market for the Application of Blood Plasma Products in Other Areas, by Region, Through 2023
    • Table 24: Global Market for Blood Plasma Products, by End User, Through 2023
    • Table 25: Global Market for Blood Plasma Products Used in Hospitals and Clinics, by Region, Through 2023
    • Table 26: Global Market for Blood Plasma Products Used in Research Laboratories, by Region, Through 2023
    • Table 27: Global Market for Blood Plasma Products Used in Academic Institutions, by Region, Through 2023
    • Table 28: Global Market for Blood Plasma Products Used in Blood Transfusion Centers, by Region, Through 2023
    • Table 29: Global Market for Blood Plasma Products, by Region, Through 2023
    • Table 30: North American Market for Blood Plasma Products, by Country, Through 2023
    • Table 31: Estimated New Cases of Cancer in the U.S., by Disease Type, 2017
    • Table 32: North American Market for Blood Plasma, by Product Type, Through 2023
    • Table 33: North American Market for Immunoglobulins, by Type, Through 2023
    • Table 34: North American Market for Blood Plasma Products, by Application, Through 2023
    • Table 35: North American Market for Blood Plasma Products, by End User, Through 2023
    • Table 36: European Market for Blood Plasma Products, by Country, Through 2023
    • Table 37: European Market for Blood Plasma, by Product Type, Through 2023
    • Table 38: European Market for Immunoglobulins, by Type, Through 2023
    • Table 39: European Market for Blood Plasma Products, by Application, Through 2023
    • Table 40: European Market for Blood Plasma Products, by End User, Through 2023
    • Table 41: Asia-Pacific Market for Blood Plasma Products, by Country, Through 2023
    • Table 42: Asia-Pacific Market for Blood Plasma, by Product Type, Through 2023
    • Table 43: Asia-Pacific Market for Immunoglobulins, by Type, Through 2023
    • Table 44: Asia-Pacific Market for Blood Plasma Products, by Application, Through 2023
    • Table 45: Asia-Pacific Market for Blood Plasma Products, by End User, Through 2023
    • Table 46: Rest of World Market for Blood Plasma Products, by Country, Through 2023
    • Table 47: Estimated Cases of Ebola Deaths in Africa, by Country, 2014-2016
    • Table 48: Rest of the World Market for Blood Plasma Products, by Product Type, Through 2023
    • Table 49: Rest of World Market for Immunoglobulins, by Type, Through 2023
    • Table 50: Rest of World Market for Blood Plasma Products, by Application, Through 2023
    • Table 51: Rest of World Market for Blood Plasma Products, by End User, Through 2023
    • Table 52: Patents Granted in North America, 2014-2017
    • Table 53: Patents Granted in Europe, 2014-2017
    • Table 54: Patents Granted in Asia-Pacific, 2014-2017
    • Table 55: Patents Granted in the RoW Region, 2014-2016
    • Table 56: Porter's Five Forces Analysis
    • Table 57: Mergers and Acquisitions
    • Table 58: New Product Launches and Product Approvals
    • Table 59: Agreements, Collaborations, Business Expansions and Partnerships
    • Table 60: ADMA Biologics Inc.: Product Portfolio
    • Table 61: ADMA Biologics Inc.: Developments and Strategies
    • Table 62: Cerus Corp.: Developments and Strategies
    • Table 63: China Biologic Products Inc.: Product Portfolio
    • Table 64: China Biologic Products Inc.: Developments and Strategies
    • Table 65: CSL Ltd.: Product Portfolio
    • Table 66: CSL Ltd.: Developments and Strategies
    • Table 67: Creat Group: Product Portfolio
    • Table 68: Creat Group: Developments and Strategies
    • Table 69: Grifols International SA: Product Portfolio
    • Table 70: Grifols International SA: Developments and Strategies
    • Table 71: Kedrion SpA: Developments and Strategies
    • Table 72: Octapharma AG: Product Portfolio
    • Table 73: Octapharma AG: Developments and Strategies
    • Table 74: Shire Plc: Product Portfolio
    • Table 75: Shire Plc: Developments and Strategies

List of Figures

  • Summary Figure: Global Market for Blood Plasma Products, by Region, 2017-2023
    • Figure 1: Role of Albumin Concentration in Maintaining Osmotic Pressure
    • Figure 2: Benefits of Blood Donation to the Donor
    • Figure 3: Distribution of Population Aged 65 and Above, by Region, 2015 and 2050
    • Figure 4: Blood Donation Globally, 2016 and 2017
    • Figure 5: FDA Regulation for Approval of Blood Products and Devices
    • Figure 6: Global Market for Blood Plasma, by Product Type, 2017-2023
    • Figure 7: Global Blood Plasma Market Share, by Product Type, 2017
    • Figure 8: Subsegments of the Market for Immunoglobulin Products
    • Figure 9: Global Immunoglobulins Market Share, by Region, 2017
    • Figure 10: Global Immunoglobulins Market Share, by Product Subsegment, 2017
    • Figure 11: Global Intravenous Immunoglobulin Market Share, by Region, 2017
    • Figure 12: Categorization of Subcutaneous Immunoglobulin
    • Figure 13: Global Subcutaneous Immunoglobulins Market Share, by Region, 2017
    • Figure 14: Global Market Share of Other Immunoglobulins, by Region, 2017
    • Figure 15: Global Albumins Market Share, by Region, 2017
    • Figure 16: Global Coagulation Factor Concentrates Market Share, by Region, 2017
    • Figure 17: Process of the Isolation of Hyperimmune Globulin
    • Figure 18: Global Hyperimmune Globulins Market Share, by Region, 2017
    • Figure 19: Global Market Share of Other Plasma Fractionation Products, by Region, 2017
    • Figure 20: Global Market for Blood Plasma Products, by Application, 2017-2023
    • Figure 21: Global Blood Plasma Products Market Share, by Application, 2017
    • Figure 22: The Study of Neurology
    • Figure 23: Role of Plasma Exchange in the Treatment of Neuroimmunological Disorders
    • Figure 24: Functions of the Immune System
    • Figure 25: Conditions Engendering Blood Transfusions
    • Figure 26: Categories of Bleeding Disorders
    • Figure 27: Symptoms of Lupus Infection
    • Figure 28: Global Market for Blood Plasma Products, by End User, 2017-2023
    • Figure 29: Global Blood Plasma Products Market Share, by End User, 2017
    • Figure 30: Role of Platelet-Rich Plasma in Treatment
    • Figure 31: Frequent Side Effects Associated with Immunoglobulin Infusions
    • Figure 32: Rarely Induced Severe Allergic Reactions Associated with Immunoglobulin Infusions
    • Figure 33: Procedure for Plasma Gel Treatment
    • Figure 34: Role of Fibrin Sealant in Coagulation Cascade
    • Figure 35: Global Market for Blood Plasma Products, by Region, 2017-2023
    • Figure 36: Global Blood Plasma Products Market Share, by Region, 2017
    • Figure 37: North American Market for Blood Plasma Products, by Country, 2017-2023
    • Figure 38: North American Blood Plasma Products Market Share, by Country, 2017
    • Figure 39: Distribution of Estimated New Cases of Cancer in the U.S., by Disease Type, 2017
    • Figure 40: U.S. Market for Blood Plasma Products, 2017-2023
    • Figure 41: Canadian Market for Blood Plasma Products, 2017-2023
    • Figure 42: Mexican Market for Blood Plasma Products, 2017-2023
    • Figure 43: European Market for Blood Plasma Products, by Country, 2017-2023
    • Figure 44: European Blood Plasma Products Market Share, by Country, 2017
    • Figure 45: German Market for Blood Plasma Products, 2017-2023
    • Figure 46: French Market for Blood Plasma Products, 2017-2023
    • Figure 47: Italian Market for Blood Plasma Products, 2017-2023
    • Figure 48: Spanish Market for Blood Plasma Products, 2017-2023
    • Figure 49: U.K. Market for Blood Plasma Products, 2017-2023
    • Figure 50: Rest of European Market for Blood Plasma Products, 2017-2023
    • Figure 51: Asia-Pacific Market for Blood Plasma Products, by Country, 2017-2023
    • Figure 52: Asia-Pacific Blood Plasma Products Market Share, by Country, 2017
    • Figure 53: Japanese Market for Blood Plasma Products, 2017-2023
    • Figure 54: Chinese Market for Blood Plasma Products, 2017-2023
    • Figure 55: Indian Market for Blood Plasma Products, 2017-2023
    • Figure 56: Australian Market for Blood Plasma Products, 2017-2023
    • Figure 57: South Korean Market for Blood Plasma Products, 2017-2023
    • Figure 58: Rest of Asia-Pacific Market for Blood Plasma Products, 2017-2023
    • Figure 59: Rest of World Market for Blood Plasma Products, by Country, 2017-2023
    • Figure 60: Rest of World Blood Plasma Products Market Share, by Country, 2017
    • Figure 61: Latin American Market for Blood Plasma Products, 2017-2023
    • Figure 62: Middle Eastern Market for Blood Plasma Products, 2017-2023
    • Figure 63: African Market for Blood Plasma Products, 2017-2023
    • Figure 64: Other Countries Market for Blood Plasma Products, 2017-2023
    • Figure 65: Global Market Share of Blood Plasma Products, by Company, 2017
    • Figure 66: Major Company Development Strategies, 2015-2018
    • Figure 67: ADMA Biologics Inc.: Financials, 2015-2017
    • Figure 68: ADMA Biologics Inc.: Revenue Share, by Segment, 2017
    • Figure 69: Baxter International: Financials, 2015-2017
    • Figure 70: Cerus Corp.: Financials, 2015-2017
    • Figure 71: China Biologic Products Inc.: Financials, 2015-2017
    • Figure 72: CSL Ltd.: Financials, 2015-2017
    • Figure 73: Grifols International SA: Financials, 2015-2017
    • Figure 74: Kedrion SpA: Financials, 2015-2017
    • Figure 75: Kedrion SpA: Revenue Share, by Segment, 2017
    • Figure 76: Octapharma AG: Financials, 2015-2017
    • Figure 77: Shire Plc: Financials, 2015-2017
    • Figure 78: Shire Plc: Revenue Share, by Segment, 2017
Back to Top